![Marc Gleeson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc Gleeson
Amministratore Delegato presso Azura Ophthalmics Pty Ltd.
Posizioni attive di Marc Gleeson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Azura Ophthalmics Pty Ltd.
![]() Azura Ophthalmics Pty Ltd. Medical SpecialtiesHealth Technology Azura Ophthalmics Ltd. develops therapies for meibomian gland dysfunction. It offers a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for meibomian gland dysfunction. The company was founded by Yair Alster in 1980 and is headquartered in Tel Aviv, Israel. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Kedalion Therapeutics, Inc.
![]() Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Direttore/Membro del Consiglio | 09/10/2019 | - |
Storia della carriera di Marc Gleeson
Precedenti posizioni note di Marc Gleeson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Elastagen Pty Ltd.
![]() Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
Australia | 2 |
Israele | 2 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 3 |
Chief Executive Officer | 1 |
Settori
Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Elastagen Pty Ltd.
![]() Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Health Technology |
Azura Ophthalmics Pty Ltd.
![]() Azura Ophthalmics Pty Ltd. Medical SpecialtiesHealth Technology Azura Ophthalmics Ltd. develops therapies for meibomian gland dysfunction. It offers a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for meibomian gland dysfunction. The company was founded by Yair Alster in 1980 and is headquartered in Tel Aviv, Israel. | Health Technology |
Kedalion Therapeutics, Inc.
![]() Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Health Technology |
- Borsa valori
- Insiders
- Marc Gleeson
- Esperienza